GAD2 and type 1 diabetes mellitus: A total of 44.2% (73/165) of young T1D patients, 45.7% (43/94) of LADY patients, 43.6% (65/149) of old T1D patients, and 26.9% (21/78) of LADA patients reacted to at least two regions of GAD65.